Evaluation of hydrogels for bio-printing applications

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 1, 2013, Pages 272-284

  Murphy, Sean V ^a   Skardal, Aleksander ^a   Atala, Anthony ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Biocompatibility; Biomaterials; Bioprinting; Gelation; Hydrogel

Indexed keywords

BIOPRINTING; BURN INJURY; COMMERCIAL AVAILABILITY; CURRENT TREATMENTS; DEPOSITION TECHNOLOGY; EASE-OF-USE; FINANCIAL ASPECTS; GELATION TIME; MEDICAL TREATMENT; SHELF LIFE; WOUND-HEALING TREATMENT;

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; BIOMATERIALS; CROSSLINKING; GELATION; ORGANIC ACIDS;

HYDROGELS;

ALGINIC ACID; CHITOSAN; COLLAGEN TYPE 1; FIBRIN; GELATIN; HYALURONIC ACID; MACROGOL; METHYLCELLULOSE; POLYETHYLENE GLYCOL DIACRYLATE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BIOPRINTING; CHEMICAL PHENOMENA; COMMERCIAL PHENOMENA; CONTROLLED STUDY; CROSS LINKING; FINANCIAL MANAGEMENT; GELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROGEL; KERATINOCYTE; LYMPHOCYTE PROLIFERATION; MOLECULAR STABILITY; SHELF LIFE; SWELLING(CHEMISTRY);

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL DEATH; CELL PROLIFERATION; HUMANS; HYDROGELS; KERATINOCYTES; LYMPHOCYTES; MATERIALS TESTING; MECHANICAL PHENOMENA; PRINTING; RATS; SOCIAL CONTROL, FORMAL; TIME FACTORS;

EID: 84872681726     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34326     Document Type: Article

References (74)

1. Burdick JA, Prestwich GD. Hyaluronic acid hydrogels for biomedical applications. Adv Mater 2011;23:H41-H56.
2. Atala A. Engineering organs. Curr Opin Biotechnol 2009;20: 575-592.
3. Miller SF, Bessey P, Lentz CW, Jeng JC, Schurr M, Browning S. National burn repository 2007 report: A synopsis of the 2007 call for data. J Burn Care Res 2008;29:862-870; discussion 871.
4. Pitts SR, Niska RW, Xu J, Burt CW. National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary. Natl Health Stat Report 2008:1-38.
5. Peck MD. Epidemiology of burns throughout the world. I. Distribution and risk factors. Burns 2011;37:1087-100.
6. Lesher AP, Curry RH, Evans J, Smith VA, Fitzgerald MT, Cina RA, Streck CJ, Hebra AV. Effectiveness of Biobrane for treatment of partial-thickness burns in children. J Pediatr Surg 2011;46: 1759-1763.
7. Rahmanian-Schwarz A, Beiderwieden A, Willkomm LM, Amr A, Schaller HE, Lotter O. A clinical evaluation of Biobrane((R)) and Suprathel((R)) in acute burns and reconstructive surgery. Burns 2011;37:1343-1348.
8. Latenser BA. Critical care of the burn patient: The first 48 hours. Crit Care Med 2009;37:2819-2826.
9. Holavanahalli RK, Helm PA, Kowalske KJ. Long-term outcomes in patients surviving large burns: The skin. J Burn Care Res 2010;31: 631-639.
10. Lloyd EC, Rodgers BC, Michener M, Williams MS. Outpatient burns: prevention and care. Am Fam Physician 2012;85:25-32.
11. Yoo JJ, Atala A, Binder KW, Zhao W, Dice D, Xu T. Delivery System. Office, United States Patent & Trademark.12/986, 812 July 14, 2011. Available at: http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2= HITOFF&d=PG01&p=1&u=/netahtml/PTO/srchnum.html&r=1&f= G&l=50&s1=20110172611.PGNR.
12. Visconti RP, Kasyanov V, Gentile C, Zhang J, Markwald RR, Mironov V. Towards organ printing: Engineering an intra-organ branched vascular tree. Expert Opin Biol Ther 2010;10:409-420.
13. Fedorovich NE, Alblas J, de Wijn JR, Hennink WE, Verbout AJ, Dhert WJ. Hydrogels as extracellular matrices for skeletal tissue engineering: State-of-the-art and novel application in organ printing. Tissue Eng 2007;13:1905-1925.
14. Mironov V, Boland T, Trusk T, Forgacs G, Markwald RR. Organ printing: Computer-aided jet-based 3D tissue engineering. Trends Biotechnol 2003;21:157-161.
15. Mironov V, Kasyanov V, Drake C, Markwald RR. Organ printing: Promises and challenges. Regen Med 2008;3:93-103.
16. Boland T, Mironov V, Gutowska A, Roth EA, Markwald RR. Cell and organ printing 2: Fusion of cell aggregates in three-dimensional gels. Anat Rec A Discov Mol Cell Evol Biol 2003;272: 497-502.
17. Jakab K, Damon B, Neagu A, Kachurin A, Forgacs G. Three-dimensional tissue constructs built by bioprinting. Biorheology 2006;43(3-4):509-513.
18. Marga F, Neagu A, Kosztin I, Forgacs G. Developmental biology and tissue engineering. Birth Defects Res C Embryo Today 2007; 81:320-328.
19. Norotte C, Marga FS, Niklason LE, Forgacs G. Scaffold-free vascular tissue engineering using bioprinting. Biomaterials 2009;30: 5910-5917.
20. Skardal A, Zhang J, Prestwich GD. Bioprinting vessel-like constructs using hyaluronan hydrogels crosslinked with tetrahedral polyethylene glycol tetracrylates. Biomaterials 2010;31:6173-6181.
21. Jakab K, Damon B, Marga F, Doaga O, Mironov V, Kosztin I, Markwald R, Forgacs G. Relating cell and tissue mechanics: Implications and applications. Dev Dyn 2008;237:2438-2449.
22. Jakab K, Neagu A, Mironov V, Markwald RR, Forgacs G. Engineering biological structures of prescribed shape using self-assembling multicellular systems. Proc Natl Acad Sci USA 2004;101: 2864-2869.
23. Skardal A, Zhang J, McCoard L, Oottamasathien S, Prestwich GD. Dynamically crosslinked gold nanoparticle - Hyaluronan hydrogels. Adv Mater 2010;22:4736-4740.
24. Skardal A, Zhang J, McCoard L, Xu X, Oottamasathien S, Prestwich GD. Photocrosslinkable hyaluronan-gelatin hydrogels for two-step bioprinting. Tissue Eng Part A 2010;16:2675-2685.
25. F.D.A. EVOLENCE® Collagen Filler - P070013. U.S. Food and Drug Administration; 2008.
26. KCL. AlloDerm® Regenerative Tissue Matrix. LifeCell Corporation; 2012.
27. F.D.A. INTEGRA MESHED BILAYER WOUND MATRIX - K081635. U.S. Food and Drug Administration; 2008.
28. Corgel Biohydrogel (TS-NaHy). Lifecore Biomedical; 2012.
29. Extracel™ Hydrogel. Glycosan BioSystems, Inc; 2007.
30. F.D.A. Restylane™ Injectable Gel-P020023. U.S. Food and Drug Administration; 2003.
31. F.D.A. CELOX PRO-K093593. U.S. Food and Drug Administration; 2010.
32. F.D.A. Hydrogel Wound Filler And 3M; Tegagel; Wound Filler With Gauze. U.S. Food and Drug Administration; 2012.
33. F.D.A. Phytacare Alginate Hydrogel Wound Dressing - K980132. U.S. Food and Drug Administration; 1998.
34. F.D.A. Intrasite Gel (labeling Revision)-K901878. U.S. Food and Drug Administration; 1990.
35. F.D.A. DuraSeal Spine Sealant System-P080013. U.S. Food and Drug Administration; 2009.
36. Prestwich GD. Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine. J Control Release 2011;155:193-199.
37. Kirker KR, Luo Y, Morris SE, Shelby J, Prestwich GD. Glycosaminoglycan hydrogels as supplemental wound dressings for donor sites. J Burn Care Rehabil 2004;25:276-286.
38. Li Y, Rodrigues J, Tomas H. Injectable and biodegradable hydrogels: Gelation, biodegradation and biomedical applications. Chem Soc Rev 2012;41:2193-2221.
39. Ribeiro MP, Espiga A, Silva D, Baptista P, Henriques J, Ferreira C, Silva JC, Borges JP, Pires E, Chaves P, et al. Development of a new chitosan hydrogel for wound dressing. Wound Repair Regen 2009;17:817-824.
40. Tran NQ, Joung YK, Lih E, Park KD. In situ forming and rutinreleasing chitosan hydrogels as injectable dressings for dermal wound healing. Biomacromolecules 2011;12:2872-2880.
41. Lee KY, Mooney DJ. Alginate: Properties and biomedical applications. Prog Polym Sci 2012;37:106-126.
42. Chiu CT, Lee JS, Chu CS, Chang YP, Wang YJ. Development of two alginate-based wound dressings. J Mater Sci Mater Med 2008;19:2503-2513.
43. Song A, Rane AA, Christman KL. Antibacterial and cell-adhesive polypeptide and poly(ethylene glycol) hydrogel as a potential scaffold for wound healing. Acta Biomater 2012;8:41-50.
44. Tibbitt MW, Anseth KS. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 2009;103:655-663.
45. Gupta D, Tator CH, Shoichet MS. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials 2006;27:2370-2379.
46. Tate MC, Shear DA, Hoffman SW, Stein DG, LaPlaca MC. Biocompatibility of methylcellulose-based constructs designed for intracerebral gelation following experimental traumatic brain injury. Biomaterials 2001;22:1113-1123.
47. Keefe J, Wauk L, Chu S, DeLustro F. Clinical use of injectable bovine collagen: A decade of experience. Clin Mater 1992;9:155-162.
48. Groenewold MD, Gribnau AJ, Ubbink DT. Topical haemostatic agents for skin wounds: A systematic review. BMC Surg 2011;11:15.
49. Dhillon S. Fibrin sealant (evicel(R) [quixil(R)/crosseal]): A review of its use as supportive treatment for haemostasis in surgery. Drugs 2011;71:1893-1915.
50. Shu XZ, Ahmad S, Liu Y, Prestwich GD. Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering. J Biomed Mater Res A 2006;79:902-912.
51. Zheng Shu X, Liu Y, Palumbo FS, Luo Y, Prestwich GD. In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials 2004;25:1339-1348.
52. Fumoto H, Takaseya T, Shiose A, Saraiva RM, Arakawa Y, et al. Mitral annular remodeling to treat functional mitral regurgitation: A pilot acute study in a canine model. Heart Surg Forum 2010;13: E247-E250.
53. Kang CE, Poon PC, Tator CH, Shoichet MS. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair. Tissue Eng Part A 2009;15:595-604.
54. Gupta D, Tator CH, Shoichet MS. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials 2006;27:2370-2379.
55. Masuda A, Goto Y, Kurosaki Y, Aiba T. In vivo application of chitosan to facilitate intestinal acyclovir absorption in rats. J Pharmac Sci 2012;101:2449-2456.
56. Mhurchu CN, Dunshea-Mooij C, Bennett D, Rodgers A. Effect of chitosan on weight loss in overweight and obese individuals: A systematic review of randomized controlled trials. Obesity Reviews 2005;6:35-42.
57. Damour O, Gueugniaud PY, Berthin-Maghit M, Rousselle P, Berthod F, et al. A dermal substrate made of collagen-GAG-chitosan for deep burn coverage: First clinical uses. Clin Mater 1994;15: 273-276.
58. Thomas S. Alginate dressings in surgery and wound management, Part 1. J Wound Care 2000;9:56-60.
59. Xia Y, Mei F, Duan Y, Gao Y, Xiong Z, et al. Bone tissue engineering using bone marrow stromal cells and an injectable sodium alginate/gelatin scaffold. J Biomed Mater Res Part A 2012;100: 1044-1050.
60. Narayani R, Rao KP. Polymer-coated gelatin capsules as oral delivery devices and their gastrointestinal tract behaviour in humans. J Biomater Sci Polym Ed 1995;7:39-48.
61. Boogaarts JD, Grotenhuis JA, Bartels RH, Beems T. Use of a novel absorbable hydrogel for augmentation of dural repair: Results of a preliminary clinical study. Neurosurgery 2005;57: 146-151; discussion 146-151.
62. Tomycz ND, Moossy JJ. DuraSeal for paddle lead anchoring during revision spinal cord stimulator surgery: A technical case report. Clin Neurol Neurosurg 2012;114:57-59.
63. Chang R, Nam J, Sun W. Direct cell writing of 3D microorgan for in vitro pharmacokinetic model. Tissue Eng C Methods 2008;14: 157-166.
64. Nakamura M, Iwanaga S, Henmi C, Arai K, Nishiyama Y. Biomatrices and biomaterials for future developments of bioprinting and biofabrication. Biofabrication 2010;2:014110.
65. Queen D, Gaylor JD, Evans JH, Courtney JM, Reid WH. The preclinical evaluation of the water vapour transmission rate through burn wound dressings. Biomaterials 1987;8:367-371.
66. Hunt TK. Wound management and infection. J Trauma 1979; 19(11 Suppl):890-891.
67. Bidarra SJ, Barrias CC, Fonseca KB, Barbosa MA, Soares RA, Granja PL. Injectable in situ crosslinkable RGD-modified alginate matrix for endothelial cells delivery. Biomaterials 2011;32: 7897-7904.
68. Jaiswal M, Koul V, Dinda AK, Mohanty S, Jain KG. Cell adhesion and proliferation studies on semi-interpenetrating polymeric networks (semi-IPNs) of polyacrylamide and gelatin. J Biomed Mater Res B Appl Biomater 2011;98:342-350.
69. Sargeant TD, Desai AP, Banerjee S, Agawu A, Stopek JB. An in situ forming collagen-PEG hydrogel for tissue regeneration. Acta biomaterialia 2012;8:124-132.
70. Soo C, Rahbar G, Moy RL. The immunogenicity of bovine collagen implants. J Dermatologic Surg Oncol 1993;19:431-434.
71. DeLustro F, Dasch J, Keefe J, Ellingsworth L. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin Orthopaedics Related Res 1990;260:263-279.
72. Ehrenreich M, Ruszczak Z. Update on tissue-engineered biological dressings. Tissue Eng 2006;12:2407-2424.
73. Liu Y, Shu XZ, Prestwich GD. Reduced postoperative intra-abdominal adhesions using Carbylan-SX, a semisynthetic glycosaminoglycan hydrogel. Fertility Sterility 2007;87:940-948.
74. Liu Y, Skardal A, Shu XZ, Prestwich GD. Prevention of peritendinous adhesions using a hyaluronan-derived hydrogel film following partial-thickness flexor tendon injury. J Orthopaedic Res 2008; 26:562-569.